LIVIVO - Das Suchportal für Lebenswissenschaften

switch to English language
Erweiterte Suche

Ihre letzten Suchen

  1. AU="Riches, Lucy"
  2. AU=Sozkes Sarkis AU=Sozkes Sarkis
  3. AU="Patrignelli, Robert"
  4. AU="Muzamil shah"
  5. AU="Bhat, Aishwarya"
  6. AU="Hossain, Md Zakir"
  7. AU=Jiang Xianhan
  8. AU="Mousavi, Seyyed Meysam"
  9. AU=Paulson J C
  10. AU="Saif, Tahir"
  11. AU=Alam Sabiha AU=Alam Sabiha
  12. AU="Braniff, Julia"
  13. AU="Kasim, Sazzli"
  14. AU=Brown Samuel M
  15. AU="Daubenberger, Claudia A."
  16. AU="Esteban, L"
  17. AU=Tyrka Audrey R.
  18. AU="Álvarez-Valenzuela, Francisco D"
  19. AU="Akrofi, M.M."
  20. AU="Torres, Daiana Rodrigues"
  21. AU="Bercovici, Nicholas"
  22. AU="Di Maio, Ginevra"
  23. AU="Indelicarto, Matthew"
  24. AU="Ma, Yan"
  25. AU="Ngan, CDR Kelly"
  26. AU="Arzamendi, Dabit"
  27. AU="Rezende, Carlos Eduardo Borges"
  28. AU="Brunvand, E."
  29. AU="Gateno, Jaime"

Suchergebnis

Treffer 1 - 5 von insgesamt 5

Suchoptionen

  1. Artikel ; Online: A molecular beacon approach to detecting RAD52 expression in response to DNA damage in human cells.

    Riches, Lucy C / Lynch, Anthony M / Gooderham, Nigel J

    Toxicology in vitro : an international journal published in association with BIBRA

    2010  Band 24, Heft 2, Seite(n) 652–660

    Abstract: Although DNA damage proteins are infrequently regulated at the transcriptional level, RAD52 mRNA levels appear to be significantly induced in human cells following methyl methanesulphonate (MMS) and Etoposide treatment. Studies have so far been limited ... ...

    Abstract Although DNA damage proteins are infrequently regulated at the transcriptional level, RAD52 mRNA levels appear to be significantly induced in human cells following methyl methanesulphonate (MMS) and Etoposide treatment. Studies have so far been limited to biochemical analysis of cellular extracts and we aimed to extend this observation to whole cells. To address this, we have developed a series of molecular beacon (MB) probes that fluoresce upon hybridising with RAD52 mRNA sequence. MB's are synthetic hairpin probes, which generate a significant fluorescent signal only upon hybridising complementary nucleotide. Three MB's are described herein, which display differential sensitivity, specificity and stability. In particular, the suitability of a texas red-labelled DNA MB (TR-MB), a dual-labelled (FAM-TAMRA) fluorescence resonance energy transfer-capable DNA MB (FRET-MB) and a FAM-labelled MB of 2'-O-methylated RNA backbone (FAM-MB) was investigated. We conclude that FAM-MB is most suitable for intracellular applications, and demonstrate a positive correlation between MB fluorescence intensity, RAD52 gene expression and both gamma ionising radiation and MMS concentration in human TK6 cells. RAD52 contribution to DNA repair has been ascribed to its role in homologous recombination (HR) and therefore we propose FAM-MB could be a potential tool for discriminating between substrates of HR and non-homologous end joining (NHEJ).
    Mesh-Begriff(e) Antineoplastic Agents, Alkylating/toxicity ; Antineoplastic Agents, Phytogenic/toxicity ; Biological Assay ; Cell Line, Tumor ; Cell-Free System ; DNA Breaks, Double-Stranded/drug effects ; DNA Repair ; Etoposide/toxicity ; Gene Expression Regulation/drug effects ; Humans ; Methyl Methanesulfonate/toxicity ; Rad52 DNA Repair and Recombination Protein/genetics ; Rad52 DNA Repair and Recombination Protein/metabolism
    Chemische Substanzen Antineoplastic Agents, Alkylating ; Antineoplastic Agents, Phytogenic ; RAD52 protein, human ; Rad52 DNA Repair and Recombination Protein ; Etoposide (6PLQ3CP4P3) ; Methyl Methanesulfonate (AT5C31J09G)
    Sprache Englisch
    Erscheinungsdatum 2010-03
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't
    ZDB-ID 639064-x
    ISSN 1879-3177 ; 0887-2333
    ISSN (online) 1879-3177
    ISSN 0887-2333
    DOI 10.1016/j.tiv.2009.09.019
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  2. Artikel ; Online: Early events in the mammalian response to DNA double-strand breaks.

    Riches, Lucy C / Lynch, Anthony M / Gooderham, Nigel J

    Mutagenesis

    2008  Band 23, Heft 5, Seite(n) 331–339

    Abstract: Physical and chemical agents that induce DNA double-strand breaks (DSBs) are among the most potent mutagens. The mammalian cell response to DSB comprises a highly co-ordinated, yet complex network of proteins that have been categorized as sensors, signal ...

    Abstract Physical and chemical agents that induce DNA double-strand breaks (DSBs) are among the most potent mutagens. The mammalian cell response to DSB comprises a highly co-ordinated, yet complex network of proteins that have been categorized as sensors, signal transducers, mediators and effectors of damage and repair. While this provides an accessible classification system, review of the literature indicates that many proteins satisfy the criteria of more than one category, pointing towards a series of highly co-operative pathways with overlapping function. In summary, the MRE11-NBS1-RAD50 complex is necessary for achieving optimal activation of ataxia-telangiectasia-mutated (ATM) kinase, which catalyses a phosphorylation-mediated signal transduction cascade. Among the subset of proteins phosphorylated by ATM are histone H2AX (H2AX), mediator of damage checkpoint protein 1, nibrin (NBS1), P53-binding protein 1 and breast cancer protein 1, all of which subsequently redistribute into DSB-containing sub-nuclear compartments. Post-translational modification of DSB responding proteins achieves a rapid and reversible change in protein behaviour and mediates damage-specific interactions, hence imparting a high degree of vigilance to the cell. This review highlights events fundamental in maintaining genetic integrity with emphasis on early stages of the DSB response.
    Mesh-Begriff(e) Acid Anhydride Hydrolases ; Animals ; Ataxia Telangiectasia Mutated Proteins ; Cell Cycle Proteins/metabolism ; DNA Breaks, Double-Stranded ; DNA Repair Enzymes ; DNA-Binding Proteins/metabolism ; Histones/metabolism ; Humans ; MRE11 Homologue Protein ; Nuclear Proteins/metabolism ; Phosphopeptides ; Protein Serine-Threonine Kinases ; Protein Structure, Tertiary ; Telomere/enzymology ; Tumor Suppressor Proteins
    Chemische Substanzen Cell Cycle Proteins ; DNA-Binding Proteins ; H2AX protein, human ; Histones ; MRE11 protein, human ; NBN protein, human ; Nuclear Proteins ; Phosphopeptides ; Tumor Suppressor Proteins ; ATM protein, human (EC 2.7.11.1) ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1) ; Protein Serine-Threonine Kinases (EC 2.7.11.1) ; MRE11 Homologue Protein (EC 3.1.-) ; Acid Anhydride Hydrolases (EC 3.6.-) ; RAD50 protein, human (EC 3.6.-) ; DNA Repair Enzymes (EC 6.5.1.-)
    Sprache Englisch
    Erscheinungsdatum 2008-07-21
    Erscheinungsland England
    Dokumenttyp Journal Article ; Research Support, Non-U.S. Gov't ; Review
    ZDB-ID 632903-2
    ISSN 1464-3804 ; 0267-8357
    ISSN (online) 1464-3804
    ISSN 0267-8357
    DOI 10.1093/mutage/gen039
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  3. Artikel ; Online: Pharmacology of the ATM Inhibitor AZD0156: Potentiation of Irradiation and Olaparib Responses Preclinically.

    Riches, Lucy C / Trinidad, Antonio G / Hughes, Gareth / Jones, Gemma N / Hughes, Adina M / Thomason, Andrew G / Gavine, Paul / Cui, Andy / Ling, Stephanie / Stott, Jonathan / Clark, Roger / Peel, Samantha / Gill, Pendeep / Goodwin, Louise M / Smith, Aaron / Pike, Kurt G / Barlaam, Bernard / Pass, Martin / O'Connor, Mark J /
    Smith, Graeme / Cadogan, Elaine B

    Molecular cancer therapeutics

    2019  Band 19, Heft 1, Seite(n) 13–25

    Abstract: AZD0156 is a potent and selective, bioavailable inhibitor of ataxia-telangiectasia mutated (ATM) protein, a signaling kinase involved in the DNA damage response. We present preclinical data demonstrating abrogation of irradiation-induced ATM signaling by ...

    Abstract AZD0156 is a potent and selective, bioavailable inhibitor of ataxia-telangiectasia mutated (ATM) protein, a signaling kinase involved in the DNA damage response. We present preclinical data demonstrating abrogation of irradiation-induced ATM signaling by low doses of AZD0156, as measured by phosphorylation of ATM substrates. AZD0156 is a strong radiosensitizer
    Mesh-Begriff(e) Animals ; Ataxia Telangiectasia Mutated Proteins/pharmacology ; Ataxia Telangiectasia Mutated Proteins/therapeutic use ; Cell Line, Tumor ; Humans ; Male ; Mice ; Mice, Nude ; Phthalazines/pharmacology ; Phthalazines/therapeutic use ; Piperazines/pharmacology ; Piperazines/therapeutic use ; Pyridines/pharmacology ; Pyridines/therapeutic use ; Quinolines/pharmacology ; Quinolines/therapeutic use ; Radiation-Sensitizing Agents/pharmacology ; Radiation-Sensitizing Agents/therapeutic use ; Triple Negative Breast Neoplasms/drug therapy ; Triple Negative Breast Neoplasms/pathology ; Triple Negative Breast Neoplasms/radiotherapy
    Chemische Substanzen Phthalazines ; Piperazines ; Pyridines ; Quinolines ; Radiation-Sensitizing Agents ; ATM protein, human (EC 2.7.11.1) ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1) ; AZD0156 (P5T0XWC07Z) ; olaparib (WOH1JD9AR8)
    Sprache Englisch
    Erscheinungsdatum 2019-09-18
    Erscheinungsland United States
    Dokumenttyp Journal Article
    ZDB-ID 2063563-1
    ISSN 1538-8514 ; 1535-7163
    ISSN (online) 1538-8514
    ISSN 1535-7163
    DOI 10.1158/1535-7163.MCT-18-1394
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  4. Artikel ; Online: The brain-penetrant clinical ATM inhibitor AZD1390 radiosensitizes and improves survival of preclinical brain tumor models.

    Durant, Stephen T / Zheng, Li / Wang, Yingchun / Chen, Kan / Zhang, Lingli / Zhang, Tianwei / Yang, Zhenfan / Riches, Lucy / Trinidad, Antonio G / Fok, Jacqueline H L / Hunt, Tom / Pike, Kurt G / Wilson, Joanne / Smith, Aaron / Colclough, Nicola / Reddy, Venkatesh Pilla / Sykes, Andrew / Janefeldt, Annika / Johnström, Peter /
    Varnäs, Katarina / Takano, Akihiro / Ling, Stephanie / Orme, Jonathan / Stott, Jonathan / Roberts, Caroline / Barrett, Ian / Jones, Gemma / Roudier, Martine / Pierce, Andrew / Allen, Jasmine / Kahn, Jenna / Sule, Amrita / Karlin, Jeremy / Cronin, Anna / Chapman, Melissa / Valerie, Kristoffer / Illingworth, Ruth / Pass, Martin

    Science advances

    2018  Band 4, Heft 6, Seite(n) eaat1719

    Abstract: Poor survival rates of patients with tumors arising from or disseminating into the brain are attributed to an inability to excise all tumor tissue (if operable), a lack of blood-brain barrier (BBB) penetration of chemotherapies/targeted agents, and an ... ...

    Abstract Poor survival rates of patients with tumors arising from or disseminating into the brain are attributed to an inability to excise all tumor tissue (if operable), a lack of blood-brain barrier (BBB) penetration of chemotherapies/targeted agents, and an intrinsic tumor radio-/chemo-resistance. Ataxia-telangiectasia mutated (ATM) protein orchestrates the cellular DNA damage response (DDR) to cytotoxic DNA double-strand breaks induced by ionizing radiation (IR). ATM genetic ablation or pharmacological inhibition results in tumor cell hypersensitivity to IR. We report the primary pharmacology of the clinical-grade, exquisitely potent (cell IC
    Mesh-Begriff(e) Animals ; Apoptosis/drug effects ; Ataxia Telangiectasia Mutated Proteins/antagonists & inhibitors ; Blood-Brain Barrier/drug effects ; Blood-Brain Barrier/metabolism ; Brain Neoplasms/drug therapy ; Brain Neoplasms/metabolism ; Brain Neoplasms/mortality ; Brain Neoplasms/pathology ; Cell Line, Tumor ; Cell Membrane Permeability ; Disease Models, Animal ; Drug Evaluation, Preclinical ; Humans ; Mice ; Phosphorylation ; Protein Kinase Inhibitors/chemistry ; Protein Kinase Inhibitors/pharmacology ; Radiation Tolerance/drug effects ; Radiation-Sensitizing Agents/chemistry ; Radiation-Sensitizing Agents/pharmacology ; Signal Transduction/drug effects ; Treatment Outcome ; Tumor Suppressor Protein p53/genetics ; Tumor Suppressor Protein p53/metabolism ; X-Rays ; Xenograft Model Antitumor Assays
    Chemische Substanzen Protein Kinase Inhibitors ; Radiation-Sensitizing Agents ; Tumor Suppressor Protein p53 ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1)
    Sprache Englisch
    Erscheinungsdatum 2018-06-20
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2810933-8
    ISSN 2375-2548 ; 2375-2548
    ISSN (online) 2375-2548
    ISSN 2375-2548
    DOI 10.1126/sciadv.aat1719
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

  5. Artikel ; Online: Orally Bioavailable and Blood-Brain Barrier-Penetrating ATM Inhibitor (AZ32) Radiosensitizes Intracranial Gliomas in Mice.

    Karlin, Jeremy / Allen, Jasmine / Ahmad, Syed F / Hughes, Gareth / Sheridan, Victoria / Odedra, Rajesh / Farrington, Paul / Cadogan, Elaine B / Riches, Lucy C / Garcia-Trinidad, Antonio / Thomason, Andrew G / Patel, Bhavika / Vincent, Jennifer / Lau, Alan / Pike, Kurt G / Hunt, Thomas A / Sule, Amrita / Valerie, Nicholas C K / Biddlestone-Thorpe, Laura /
    Kahn, Jenna / Beckta, Jason M / Mukhopadhyay, Nitai / Barlaam, Bernard / Degorce, Sebastien L / Kettle, Jason / Colclough, Nicola / Wilson, Joanne / Smith, Aaron / Barrett, Ian P / Zheng, Li / Zhang, Tianwei / Wang, Yingchun / Chen, Kan / Pass, Martin / Durant, Stephen T / Valerie, Kristoffer

    Molecular cancer therapeutics

    2018  Band 17, Heft 8, Seite(n) 1637–1647

    Abstract: Inhibition of ataxia-telangiectasia mutated (ATM) during radiotherapy of glioblastoma multiforme (GBM) may improve tumor control by short-circuiting the response to radiation-induced DNA damage. A major impediment for clinical implementation is that ... ...

    Abstract Inhibition of ataxia-telangiectasia mutated (ATM) during radiotherapy of glioblastoma multiforme (GBM) may improve tumor control by short-circuiting the response to radiation-induced DNA damage. A major impediment for clinical implementation is that current inhibitors have limited central nervous system (CNS) bioavailability; thus, the goal was to identify ATM inhibitors (ATMi) with improved CNS penetration. Drug screens and refinement of lead compounds identified AZ31 and AZ32. The compounds were then tested
    Mesh-Begriff(e) Administration, Oral ; Animals ; Ataxia Telangiectasia Mutated Proteins/antagonists & inhibitors ; Blood-Brain Barrier/metabolism ; Cell Line, Tumor ; Glioma/drug therapy ; Humans ; Mice ; Mice, Nude ; Protein Kinase Inhibitors/pharmacology ; Protein Kinase Inhibitors/therapeutic use ; Radiation-Sensitizing Agents/pharmacology ; Radiation-Sensitizing Agents/therapeutic use
    Chemische Substanzen Protein Kinase Inhibitors ; Radiation-Sensitizing Agents ; Ataxia Telangiectasia Mutated Proteins (EC 2.7.11.1) ; Atm protein, mouse (EC 2.7.11.1)
    Sprache Englisch
    Erscheinungsdatum 2018-05-16
    Erscheinungsland United States
    Dokumenttyp Journal Article ; Research Support, N.I.H., Extramural ; Research Support, Non-U.S. Gov't
    ZDB-ID 2063563-1
    ISSN 1538-8514 ; 1535-7163
    ISSN (online) 1538-8514
    ISSN 1535-7163
    DOI 10.1158/1535-7163.MCT-17-0975
    Datenquelle MEDical Literature Analysis and Retrieval System OnLINE

    Zusatzmaterialien

    Kategorien

Zum Seitenanfang